placidex syrup
e.c. de witt & company limited - paracetamol - syrup
secron syrup
e.c. de witt & company limited - syrup
ondansetron- ondansetron tablet, orally disintegrating
lake erie medical dba quality care products llc - ondansetron (unii: 4af302esos) (ondansetron - unii:4af302esos) - ondansetron 4 mg - 1. prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin ≥ 50 mg/m2 . 2. prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. 3. prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. 4. prevention of postoperative nausea and/or vomiting. as with other antiemetics, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. in patients where nausea and/or vomiting must be avoided postoperatively, ondansetron hydrochloride tablets, ondansetron orally disintegrating tablets, and ondansetron hydrochloride oral solution are recommended even where the incidence of postoperative nausea and/or vomiting is low. the concomitant use of apomorphine with ondansetron is contraindic
pantoprazole 20mg gastro-resistant tablets
de pharmaceuticals - pantoprazole sodium sesquihydrate - gastro-resistant tablet - 20mg
ondansetron tablet, orally disintegrating
proficient rx lp - ondansetron (unii: 4af302esos) (ondansetron - unii:4af302esos) - 1. prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin ≥ 50 mg/m2 . 2. prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. 3. prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. 4. prevention of postoperative nausea and/or vomiting. as with other antiemetics, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. in patients where nausea and/or vomiting must be avoided postoperatively, ondansetron hydrochloride tablets, ondansetron orally disintegrating tablets, and ondansetron hydrochloride oral solution are recommended even where the incidence of postoperative nausea and/or vomiting is low. the concomitant use of apomorphine with ondansetron is contraindic
ddvap 0.2mg tablet
ferring gmbh wittland kiel 11 24109 germany - desmopressin - tablet - 0.2mg 0.1mg - posterior pituitarylobe hormones: vasopressin and
pentasa xtend sachets 2g granules for oral solution in sachet
ferring gmbh wittland 11 24109 kiel germany - mesalazine - granules for oral solution in sachet - 2g - mesalazine
holistic select large and giant breed adult health chicken meal & oatmeal recipe
wellpet, llc - omega 3 fatty acid; omega 6 fatty acid; taurine; glucosamine hydrochloride; amylase; cellulase; protease; carotene-beta; carnitine - l; total bacillus organisms; total lactic acide producing organisms; moisture; crude fat; crude fibre; crude protein; calcium; phosphorus; vitamin a; vitamin c = ascorbic acid; vitamin e - oral food (can/semi-dry/dry) - omega 3 fatty acid acid-fatty active 0.5 %; omega 6 fatty acid acid-fatty active 2.8 %; taurine amino zwitterion active 0.11 %; glucosamine hydrochloride carbohydrate-glucose active 82.0 mg/cup; amylase enzyme active 5.0 dxu/lb; cellulase enzyme active 100.0 cu/lb; protease enzyme active 280.0 hut/lb; carotene-beta vitamin-a active 5.0 mg/kg; carnitine - l vitamin-bt active 150.0 mg/kg; total bacillus organisms biological-organism active 7.0 mcfu/lb; total lactic acide producing organisms biological organism active 240.0 mcfu/lb; moisture ungrouped other 10.0 %; crude fat dietary other 14.0 %; crude fibre dietary other 3.9 %; crude protein dietary other 24.0 %; calcium mineral-calcium other 1.0 %; phosphorus mineral-phosphorus other 0.8 %; vitamin a vitamin-a other 22000.0 iu/kg; vitamin c = ascorbic acid vitamin-c other 30.0 mg/kg; vitamin e vitamin-e other 165.0 iu/kg - nutrition & metabolism - dog - extra large | dog - large - prescription diet | dietary management of obesity, | early cardiac disease | food allergy | gastrointestinal disorders | hepatitus, kidney disease, | lower urinary tract support | pancreatitis, gastroenteritis | renal function | struvite urolithiasis
votrient 400mg tablets film-coated
glaxo wellcome s.a. - pazopanib - tablets film-coated - 400mg
votrient 200mg tablets film-coated
glaxo wellcome s.a. - pazopanib - tablets film-coated - 200mg